Assessment of Positional Obstructive Sleep Apnea in Children Undergoing Adenotonsillectomy for Obstructive Sleep Apnea.

Seckin O Ulualp, Romaine F Johnson, Ron B Mitchell
Author Information
  1. Seckin O Ulualp: Department of Otolaryngology-Head and Neck Surgery University of Texas Southwestern Medical Center and Division of Pediatric Otolaryngology, Children's Medical Center Dallas Texas USA. ORCID
  2. Romaine F Johnson: Department of Otolaryngology-Head and Neck Surgery University of Texas Southwestern Medical Center and Division of Pediatric Otolaryngology, Children's Medical Center Dallas Texas USA. ORCID
  3. Ron B Mitchell: Department of Otolaryngology-Head and Neck Surgery University of Texas Southwestern Medical Center and Division of Pediatric Otolaryngology, Children's Medical Center Dallas Texas USA. ORCID

Abstract

Objectives: To determine the prevalence of positional obstructive sleep apnea (POSA) in children undergoing adenotonsillectomy (AT) for OSA and to assess whether POSA improves following AT.
Materials and Methods: children with OSA diagnosed by polysomnography (PSG) at a tertiary care children's hospital were included. Data was collected on demographics, PSG parameters, and surgical management. Statistical comparisons between groups for the prevalence of POSA were performed with the ��2 test or Fisher's exact test, for PSG parameters prior to AT with Student's -test or Mann-Whitney Rank Sum Test, and for PSG parameters before and after AT with paired t-test and Wilcoxon Signed Rank Test. ���<���0.05 was considered significant.
Results: Of the 1167 children (682 male, 485 female, median age���=���5.7���years), 321 (28%) had POSA. POSA children (median age���=���7.4���years) were older than children with no POSA (median���=���5.2) (���������0.001). The prevalence of POSA in the subgroups of gender and weight was not different. The prevalence of POSA was significantly different amongst the race groups (���=���0.005). Compared with the Black/African American race, the white race had 1.4 times the odds of POSA (95% CI, 1.07-1.98). The prevalence of POSA was not significantly different between mild, moderate, and severe OSA groups (���=���0.7). Of the 66 POSA children who had PSG pre- and post-TA, 50 (76%) had resolution of POSA. children older than 6���years of age and children with obesity had a higher rate of persistent POSA (���=���0.02 and ���=���0.008, respectively).
Conclusion: POSA occurred frequently in OSA children undergoing AT. POSA is resolved in the majority of children after AT. Persistent POSA was more prevalent in older and obese children. AT is used as the first-line treatment for POSA in children. Future studies are needed to determine the role of positional therapy and other OSA therapies in the management of persistent POSA after AT.
Level of Evidence: 4.

Keywords

References

  1. Physiol Meas. 2023 Aug 03;44(8): [PMID: 37080233]
  2. JAMA Otolaryngol Head Neck Surg. 2015 Feb;141(2):130-6 [PMID: 25474490]
  3. Am J Otolaryngol. 2018 Sep - Oct;39(5):501-506 [PMID: 29929863]
  4. J Abnorm Psychol. 1967 Jun;72(3):255-64 [PMID: 6045597]
  5. J Pediatr. 2006 Dec;149(6):803-8 [PMID: 17137896]
  6. Sleep. 2014 Feb 01;37(2):261-9 [PMID: 24497655]
  7. Arch Otolaryngol Head Neck Surg. 2011 Jul;137(7):675-9 [PMID: 21768411]
  8. Am Rev Respir Dis. 1986 Apr;133(4):662-6 [PMID: 3963630]
  9. J Clin Sleep Med. 2016 Apr 15;12(4):513-7 [PMID: 26612510]
  10. J Appl Physiol (1985). 1993 Nov;75(5):2084-90 [PMID: 8307863]
  11. Otolaryngol Head Neck Surg. 2021 Jan;164(1):191-198 [PMID: 32746692]
  12. Sleep. 1991 Aug;14(4):351-3 [PMID: 1947599]
  13. Laryngoscope. 2015 Jan;125(1):248-54 [PMID: 25154495]
  14. Arch Dis Child. 2007 Mar;92(3):205-8 [PMID: 17041010]
  15. JAMA Otolaryngol Head Neck Surg. 2019 Feb 1;145(2):159-165 [PMID: 30570656]
  16. Otolaryngol Head Neck Surg. 2014 Mar;150(3):487-93 [PMID: 24376123]
  17. J Pediatr. 2003 Apr;142(4):383-9 [PMID: 12712055]
  18. Pediatrics. 1985 May;75(5):832-5 [PMID: 3991268]
  19. Proc Am Thorac Soc. 2008 Feb 15;5(2):173-8 [PMID: 18250209]
  20. Chest. 2005 Oct;128(4):2130-7 [PMID: 16236865]
  21. Pediatr Pulmonol. 1996 Mar;21(3):176-83 [PMID: 8860073]
  22. Pediatr Clin North Am. 2013 Aug;60(4):827-40 [PMID: 23905822]
  23. Thorax. 2010 Nov;65(11):991-7 [PMID: 20965935]
  24. Med Clin North Am. 2010 Sep;94(5):1047-55 [PMID: 20736112]
  25. J Clin Sleep Med. 2022 Oct 1;18(10):2397-2404 [PMID: 35808945]
  26. Acta Otolaryngol. 2003 Oct;123(543):41-45 [PMID: 28425299]
  27. Am J Otolaryngol. 1985 Sep-Oct;6(5):373-7 [PMID: 4073378]
  28. Sleep. 2015 Sep 01;38(9):1469-78 [PMID: 25761982]
  29. Sleep Med Rev. 2023 Dec;72:101847 [PMID: 37722317]
  30. J Clin Sleep Med. 2014 Jan 15;10(1):81-8 [PMID: 24426825]
  31. Sleep Breath. 2015 May;19(2):473-80 [PMID: 24943728]
  32. Chest. 2000 Oct;118(4):1018-24 [PMID: 11035672]
  33. Sleep. 2006 Aug;29(8):1031-5 [PMID: 16944671]
  34. Sleep. 2002 Feb 1;25(1):66-71 [PMID: 11833863]
  35. Sleep. 1991 Dec;14(6):546-52 [PMID: 1798889]
  36. Pediatrics. 2003 Mar;111(3):554-63 [PMID: 12612236]
  37. Int J Pediatr Otorhinolaryngol. 2006 Sep;70(9):1555-60 [PMID: 16820218]
  38. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1527-32 [PMID: 10228121]
  39. Pediatr Pulmonol. 2003 Oct;36(4):335-8 [PMID: 12950048]
  40. J Pediatr. 1979 Feb;94(2):275-81 [PMID: 762624]
  41. Arch Dis Child. 2003 Dec;88(12):1043-7 [PMID: 14670764]
  42. Pediatr Pulmonol. 1993 Aug;16(2):124-9 [PMID: 8367218]
  43. J Clin Sleep Med. 2014 Apr 15;10(4):403-9 [PMID: 24733986]
  44. Am J Respir Crit Care Med. 1996 Feb;153(2):866-78 [PMID: 8564147]
  45. Laryngoscope. 2016 Nov;126(11):2624-2629 [PMID: 27010662]
  46. Auris Nasus Larynx. 2011 Apr;38(2):228-32 [PMID: 20800981]
  47. JAMA. 2020 Apr 14;323(14):1389-1400 [PMID: 32286648]
  48. Sleep. 1984;7(2):110-4 [PMID: 6740055]
  49. Eur Arch Otorhinolaryngol. 2019 Mar;276(3):871-878 [PMID: 30689039]
  50. Pediatr Pulmonol. 2000 Apr;29(4):284-90 [PMID: 10738016]
  51. Pediatrics. 2015 Feb;135(2):e477-86 [PMID: 25601979]
  52. Chest. 1997 Sep;112(3):629-39 [PMID: 9315794]
  53. Sleep Breath. 2014 Dec;18(4):791-7 [PMID: 24705807]
  54. Sleep Breath. 2017 May;21(2):279-288 [PMID: 27535072]
  55. Sleep Breath. 2018 Dec;22(4):939-948 [PMID: 30069673]
  56. J Clin Sleep Med. 2018 May 15;14(5):867-875 [PMID: 29734982]
  57. Proc Am Thorac Soc. 2008 Feb 15;5(2):253-62 [PMID: 18250219]
  58. Chest. 2024 Jul;166(1):212-225 [PMID: 38218217]
  59. J Clin Sleep Med. 2021 Feb 1;17(2):227-232 [PMID: 33094724]
  60. Am J Respir Crit Care Med. 1997 Jan;155(1):199-204 [PMID: 9001312]
  61. Sleep Breath. 2019 Dec;23(4):1323-1330 [PMID: 31065887]
  62. J Clin Sleep Med. 2020 Aug 15;16(8):1295-1301 [PMID: 32807295]
  63. Am J Respir Crit Care Med. 2010 Sep 1;182(5):676-83 [PMID: 20448096]
  64. Respirology. 2017 Nov;22(8):1500-1507 [PMID: 28901030]
  65. Cochrane Database Syst Rev. 2019 May 01;5:CD010990 [PMID: 31041813]
  66. Pediatr Pulmonol. 2007 Apr;42(4):374-9 [PMID: 17352403]
  67. N Engl J Med. 2013 Jun 20;368(25):2366-76 [PMID: 23692173]
  68. Laryngoscope. 2007 Oct;117(10):1844-54 [PMID: 17721406]
  69. Sleep. 2009 Jun;32(6):731-6 [PMID: 19544748]
  70. Laryngoscope. 2021 Jan;131(1):224-229 [PMID: 32511760]
  71. Am J Respir Crit Care Med. 2016 Sep 15;194(6):739-47 [PMID: 26930303]
  72. Pediatrics. 2012 Sep;130(3):576-84 [PMID: 22926173]
  73. Int J Pediatr Otorhinolaryngol. 2020 Feb;129:109763 [PMID: 31704574]

Word Cloud

Created with Highcharts 10.0.0pOSAchildrenATprevalenceOSAPSGobstructivesleepapneaPOSA���=���0positionalChildrenparametersgroupsolderdifferentracepersistentdetermineundergoingmanagementtestRankTestmediansignificantly14ObstructiveSleepApneaObjectives:adenotonsillectomyassesswhetherimprovesfollowingMaterialsMethods:diagnosedpolysomnographytertiarycarechildren'shospitalincludedDatacollecteddemographicssurgicalStatisticalcomparisonsperformed��2Fisher'sexactpriorStudent's-testMann-WhitneySumpairedt-testWilcoxonSigned���<���005consideredsignificantResults:1167682male485femaleage���=���57���years32128%age���=���74���yearsmedian���=���52���������0001subgroupsgenderweightamongst005ComparedBlack/AfricanAmericanwhitetimesodds95%CI07-198mildmoderatesevere766pre-post-TA5076%resolution6���yearsageobesityhigherrate02008respectivelyConclusion:occurredfrequentlyresolvedmajorityPersistentprevalentobeseusedfirst-linetreatmentFuturestudiesneededroletherapytherapiesLevelEvidence:AssessmentPositionalUndergoingAdenotonsillectomy

Similar Articles

Cited By

No available data.